1,405
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues

ORCID Icon, , &
Pages 177-179 | Received 19 Jan 2023, Accepted 17 Feb 2023, Published online: 27 Feb 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.